close

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.07
+3.80 (1.85%)
AAPL  272.31
+6.13 (2.30%)
AMD  212.85
+16.25 (8.27%)
BAC  50.29
-0.78 (-1.52%)
GOOG  311.21
-0.48 (-0.15%)
META  638.99
+1.74 (0.27%)
MSFT  386.62
+2.15 (0.56%)
NVDA  192.99
+1.44 (0.75%)
ORCL  145.02
+3.71 (2.62%)
TSLA  404.26
+4.43 (1.11%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today